The efficacy of a Dermatopoietin-containing cosmetic composition was evaluated in double-blind placebo-controlled clinical studies in Skin Test Institute, Neuchatel, Switzerland.
The product was applied for eight weeks on a cellulite-affected thigh of volunteers and a series of tests was made.

Results: The Dermatopoietin-containing product significantly improved the regularity of the dermal-subcutaneous border, an underlying cause of the deviation of cellulite-affected skin from the ideal form (see Fig. A ). 

Figure A:  Plot of the evolution of mean hypodermis-dermis Junction Distance (JD), as the difference between Dermatopietin and Placebo groups. B, Real ultrasonograms of the cellulite-affected area just before and after the cosmetic treatment with Dermatopoietin-containing composition (n=20).

// Cellulite Study > Summary (Link to PDF)

      

1.1 History

1.2 How it works?

1.3 Safety

1.4 Efficacy

1.5 Hexapeptide 18